Answers are grounded in this paper and cite their sources.
Although JMJD6 displays anti-tumoral properties in cell lines, its expression in breast tumours may be a marker of poor prognosis, suggesting that its function could be altered in breast cancer.
No takes yet. Share an insight, caveat, or question.
Poulard et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: